Report Summary
Eternity Insights has published a new study on Global Viral Vector Development Service Market focusing on key segments as by Type (Retroviral Vectors,Lentiviral Vectors,Adenoviral Vectors,Adeno-associated Viral Vectors,Other Viral Vectors), by Application (Pharmaceutical Manufacturers,Biotechnology Companies,Research Institutes, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Viral Vector Development Service Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Viral Vector Development Service Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Viral Vector Development Service Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Viral Vector Development Service Market Segmentation:
Viral Vector Development Service Market, By Type
- Retroviral Vectors
- Lentiviral Vectors
- Adenoviral Vectors
- Adeno-associated Viral Vectors
- Other Viral Vectors
Viral Vector Development Service Market, By Application
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Research Institutes
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Viral Vector Development Service market in terms of demand generation. The Viral Vector Development Service market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Viral Vector Development Service market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Viral Vector Development Service Market Taxonomy:
To learn more about this report
Global Viral Vector Development Service Market Competitive Landscape
The global Viral Vector Development Service market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Kaneka Eurogentec
- FinVector
- Brammer Bio
- Cell and Gene Therapy Catapult
- FUJIFILM Diosynth Biotechnologies
- Sanofi
- Spark Therapeutics
- Cobra Biologics
- UniQure and MassBiologics
- Renova Therapeutics
- Shenzhen SiBiono GeneTech
- Thermo Fisher Scientific
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Retroviral Vectors,Lentiviral Vectors,Adenoviral Vectors,Adeno-associated Viral Vectors,Other Viral Vectors |
| By Application Outlook |
Pharmaceutical Manufacturers,Biotechnology Companies,Research Institutes, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Kaneka Eurogentec,FinVector,Brammer Bio,Cell and Gene Therapy Catapult,FUJIFILM Diosynth Biotechnologies,Sanofi,Spark Therapeutics,Cobra Biologics,UniQure and MassBiologics,Renova Therapeutics,Shenzhen SiBiono GeneTech,Thermo Fisher Scientific |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Viral Vector Development Service Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Viral Vector Development Service Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Viral Vector Development Service Market Performance
2.3 USA Viral Vector Development Service Market Performance
2.4 Europe Viral Vector Development Service Market Performance
2.5 Japan Viral Vector Development Service Market Performance
2.6 Korea Viral Vector Development Service Market Performance
2.7 India Viral Vector Development Service Market Performance
2.8 Southeast Asia Viral Vector Development Service Market Performance
2.9 South America Viral Vector Development Service Market Performance
3 Global Viral Vector Development Service Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Viral Vector Development Service Market Performance (Volume)
3.3 USA Viral Vector Development Service Market Performance (Volume)
3.4 Europe Viral Vector Development Service Market Performance (Volume)
3.5 Japan Viral Vector Development Service Market Performance (Volume)
3.6 Korea Viral Vector Development Service Market Performance (Volume)
3.7 India Viral Vector Development Service Market Performance (Volume)
3.8 Southeast Asia Viral Vector Development Service Market Performance (Volume)
3.9 South America Viral Vector Development Service Market Performance (Volume)
4 Competitive Analysis
4.1 Kaneka Eurogentec
4.1.1 Kaneka Eurogentec Profiles
4.1.2 Kaneka Eurogentec Product Information
4.1.3 Kaneka Eurogentec Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.1.4 Kaneka Eurogentec Viral Vector Development Service Business Performance
4.1.5 SWOT Analysis
4.2 FinVector
4.2.1 FinVector Profiles
4.2.2 FinVector Product Information
4.2.3 FinVector Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.2.4 FinVector Viral Vector Development Service Business Performance
4.2.5 SWOT Analysis
4.3 Brammer Bio
4.3.1 Brammer Bio Profiles
4.3.2 Brammer Bio Product Information
4.3.3 Brammer Bio Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.3.4 Brammer Bio Viral Vector Development Service Business Performance
4.3.5 SWOT Analysis
4.4 Cell and Gene Therapy Catapult
4.4.1 Cell and Gene Therapy Catapult Profiles
4.4.2 Cell and Gene Therapy Catapult Product Information
4.4.3 Cell and Gene Therapy Catapult Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.4.4 Cell and Gene Therapy Catapult Viral Vector Development Service Business Performance
4.4.5 SWOT Analysis
4.5 FUJIFILM Diosynth Biotechnologies
4.5.1 FUJIFILM Diosynth Biotechnologies Profiles
4.5.2 FUJIFILM Diosynth Biotechnologies Product Information
4.5.3 FUJIFILM Diosynth Biotechnologies Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.5.4 FUJIFILM Diosynth Biotechnologies Viral Vector Development Service Business Performance
4.5.5 SWOT Analysis
4.6 Sanofi
4.6.1 Sanofi Profiles
4.6.2 Sanofi Product Information
4.6.3 Sanofi Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.6.4 Sanofi Viral Vector Development Service Business Performance
4.6.5 SWOT Analysis
4.7 Spark Therapeutics
4.7.1 Spark Therapeutics Profiles
4.7.2 Spark Therapeutics Product Information
4.7.3 Spark Therapeutics Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.7.4 Spark Therapeutics Viral Vector Development Service Business Performance
4.7.5 SWOT Analysis
4.8 Cobra Biologics
4.8.1 Cobra Biologics Profiles
4.8.2 Cobra Biologics Product Information
4.8.3 Cobra Biologics Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.8.4 Cobra Biologics Viral Vector Development Service Business Performance
4.8.5 SWOT Analysis
4.9 UniQure and MassBiologics
4.9.1 UniQure and MassBiologics Profiles
4.9.2 UniQure and MassBiologics Product Information
4.9.3 UniQure and MassBiologics Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.9.4 UniQure and MassBiologics Viral Vector Development Service Business Performance
4.9.5 SWOT Analysis
4.10 Renova Therapeutics
4.10.1 Renova Therapeutics Profiles
4.10.2 Renova Therapeutics Product Information
4.10.3 Renova Therapeutics Viral Vector Development Service Production, Revenue, Price and Gross Margin
4.10.4 Renova Therapeutics Viral Vector Development Service Business Performance
4.10.5 SWOT Analysis
4.11 Shenzhen SiBiono GeneTech
4.12 Thermo Fisher Scientific
5 Competitive Landscape
5.1 Global Viral Vector Development Service Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Viral Vector Development Service Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Viral Vector Development Service Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Viral Vector Development Service Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Viral Vector Development Service Market Assessment by Regions
6.1 Global Viral Vector Development Service Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Viral Vector Development Service Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Viral Vector Development Service Price (USD/Unit) by Regions (2014-2020)
6.4 Global Viral Vector Development Service Gross Margin by Regions (2014-2020)
7 Viral Vector Development Service Regional Analysis
7.1 China Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.2 USA Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.6 India Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
7.8 South America Viral Vector Development Service Production, Revenue and Growth Rate (2014-2020)
8 Global Viral Vector Development Service Consumption Assessment
8.1 Global Viral Vector Development Service Consumption and Market Share by Regions (2014-2020)
8.2 Global Viral Vector Development Service Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Viral Vector Development Service Average Price (USD/Unit) by Regions (2014-2020)
9 Global Viral Vector Development Service Sales Assessment by Regions
9.1 Global Viral Vector Development Service Sales and Sales Value (2014-2020)
9.2 China Viral Vector Development Service Sales and Sales Value (2014-2020)
9.3 USA Viral Vector Development Service Sales and Sales Value (2014-2020)
9.4 Europe Viral Vector Development Service Sales and Sales Value (2014-2020)
9.5 Japan Viral Vector Development Service Sales and Sales Value (2014-2020)
9.6 Korea Viral Vector Development Service Sales and Sales Value (2014-2020)
9.7 India Viral Vector Development Service Sales and Sales Value (2014-2020)
9.8 Southeast Asia Viral Vector Development Service Sales and Sales Value (2014-2020)
9.9 South America Viral Vector Development Service Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Viral Vector Development Service Production and Revenue by Regions 2021-2026
12.1.2 China Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.7 India Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Viral Vector Development Service Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Viral Vector Development Service Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.3 China Viral Vector Development Service Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.8 India Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.2.10 South America Viral Vector Development Service Sales and Sales Value Forecast 2021-2026
12.3 Global Viral Vector Development Service Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 Retroviral Vectors
12.3.3 Lentiviral Vectors
12.3.4 Adenoviral Vectors
12.3.5 Adeno-associated Viral Vectors
12.3.6 Other Viral Vectors
12.4 Global Viral Vector Development Service Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Pharmaceutical Manufacturers
12.4.3 Biotechnology Companies
12.4.4 Research Institutes
12.5 Global Viral Vector Development Service Price and Gross Margin Forecast
13.5.1 Global Viral Vector Development Service Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Viral Vector Development Service Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
